Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.

[1]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[2]  R. Senior,et al.  Myocardial Contrast Echocardiography for Distinguishing Ischemic From Nonischemic First-Onset Acute Heart Failure: Insights Into the Mechanism of Acute Heart Failure , 2005, Circulation.

[3]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[4]  F. Ridocci,et al.  Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.

[5]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[6]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[7]  M. Pfeffer,et al.  An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. , 2004, European heart journal.

[8]  P. Danias,et al.  Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. , 2004, The American journal of cardiology.

[9]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[10]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[11]  D. Pennell,et al.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.

[12]  Dipan J. Shah,et al.  Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.

[13]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[14]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[15]  D. Pennell,et al.  Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. , 2003, Circulation.

[16]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[17]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[18]  C. O'connor,et al.  A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.

[19]  K. Swedberg,et al.  Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology , 2002, European journal of heart failure.

[20]  Ali Massumi,et al.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. , 2002, Texas Heart Institute journal.

[21]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[22]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[23]  M A Hlatky,et al.  American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001 .

[24]  M. Dellborg,et al.  ECG criteria in diagnosis of acute myocardial infarction in the presence of left bundle branch block. , 2001, International journal of cardiology.

[25]  E. Topol,et al.  Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.

[26]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[27]  S. Rahimtoola.  Concept and evaluation of hibernating myocardium. , 1999, Annual review of medicine.

[28]  M. Budoff,et al.  Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[29]  W. Schaper,et al.  Hibernating myocardium: an incomplete adaptation to ischemia. , 1997, Circulation.

[30]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[31]  J. Valty,et al.  Is Dobutamine Stress Echocardiography Useful for Noninvasive Differentiation of Ischemic from Idiopathic Dilated Cardiomyopathy? , 1997, Angiology.

[32]  A. Soricelli,et al.  Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. , 1996, Circulation.

[33]  J. Balligand,et al.  Nitric oxide and cardiac function. , 1996, Circulation research.

[34]  G. Perna,et al.  Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. , 1996, American heart journal.

[35]  W. Paulus,et al.  Paracrine coronary endothelial control of left ventricular function in humans. , 1995, Circulation.

[36]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[37]  N. Fineberg,et al.  Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. , 1994, Journal of the American College of Cardiology.

[38]  E. Cottington,et al.  Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[39]  N. Fineberg,et al.  Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. , 1992, Journal of the American College of Cardiology.

[40]  J. Corbett,et al.  Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. , 1992, Archives of internal medicine.

[41]  Y. Doi,et al.  Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. , 1992, The American journal of cardiology.

[42]  T. Lüscher,et al.  Endothelium-derived contracting factors. , 1992, Hypertension.

[43]  M. Pfeffer,et al.  Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. , 1991, The American journal of cardiology.

[44]  P. Nihoyannopoulos,et al.  Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. , 1991, The American journal of cardiology.

[45]  M. Phelps,et al.  Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. , 1991, Journal of the American College of Cardiology.

[46]  B. Sobel,et al.  Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. , 1987, The American journal of cardiology.

[47]  A. Hakki,et al.  Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction. , 1986, American heart journal.

[48]  R. Henkin,et al.  Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. , 1984, Journal of the American College of Cardiology.